Policies that promote the long-term sustainability of the U.S. generic pharmaceutical industry and preserve reliable patient access to affordable medicines.
2026 · 2nd Quarter (Apr 1 - June 30)
LUPIN PHARMACEUTICALS
Filed by MEDSECUREAN.COM.
Open official filingSource-reported fields
Filing overview
- Type
- 2nd Quarter - Report
- Posted
- Jul 13, 2026
- Income
- $54,000.00
- Expenses
- Not reported
- Registrant
- MEDSECUREAN.COM
- Client
- LUPIN PHARMACEUTICALS
- Filing UUID
- ca1a24f2-472e-4457-a063-072349ca5ed1
- Termination date
- Not reported
Literal source text
Lobbying issues and bill citations
Tarrifs - generic medicine
Relationship and amount limits
Bill links use only the filing year’s mathematically derived Congress plus the literal measure type and number in the issue description. Unmatched citations remain plain text. Politically.com does not join on names, infer advocacy positions, combine amendments, or calculate totals across filings.